Overview
Stacey Goodman is a Hematologist in Nashville, Tennessee. Dr. Goodman is rated as an Experienced provider by MediFind in the treatment of Schnitzler Syndrome. Her top areas of expertise are Primary Amyloidosis, Multiple Myeloma, Cardiac Amyloidosis, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant.
Her clinical research consists of co-authoring 28 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Vanderbilt University
Aaron Shaver is a Hematologist in Nashville, Tennessee. Dr. Shaver is rated as a Distinguished provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Primary Amyloidosis, and Monoclonal Gammopathy of Undetermined Significance (MGUS).
Vanderbilt Health Clinicians, LLC
Muhamed Baljevic is a Hematologist Oncology specialist and a Hematologist in Nashville, Tennessee. Dr. Baljevic is rated as a Distinguished provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Baljevic is currently accepting new patients.
Vanderbilt University
Adam Seegmiller is a Hematologist in Nashville, Tennessee. Dr. Seegmiller is rated as a Distinguished provider by MediFind in the treatment of Schnitzler Syndrome. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Monoclonal Gammopathy of Undetermined Significance (MGUS).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Primary AmyloidosisDr. Goodman isElite. Learn about Primary Amyloidosis.
- Distinguished
- Cardiac AmyloidosisDr. Goodman isDistinguished. Learn about Cardiac Amyloidosis.
- Multiple MyelomaDr. Goodman isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Goodman isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Cerebral Amyloid AngiopathyDr. Goodman isAdvanced. Learn about Cerebral Amyloid Angiopathy.
- Hereditary Cerebral Amyloid Angiopathy
- Primary Localized Cutaneous Amyloidosis
- Smoldering Multiple MyelomaDr. Goodman isAdvanced. Learn about Smoldering Multiple Myeloma.
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Goodman isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Bone Marrow TransplantDr. Goodman isExperienced. Learn about Bone Marrow Transplant.
- Chronic Graft Versus Host Disease (cGvHD)Dr. Goodman isExperienced. Learn about Chronic Graft Versus Host Disease (cGvHD).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Goodman isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- End-Stage Renal Disease (ESRD)Dr. Goodman isExperienced. Learn about End-Stage Renal Disease (ESRD).
- Graft Versus Host Disease (GvHD)Dr. Goodman isExperienced. Learn about Graft Versus Host Disease (GvHD).